Preliminary results suggest anti-COVID19 nanobodies may be effective at preventing and diagnosing infections.
According to researchers, antibodies against seasonal coronaviruses are not able to protect against severe COVID-19 infection.
Researchers have determined 3D shapes of eight neutralizing antibodies attached to SARS-CoV-2.
The rate of COVID-19 transmission is unaffected by the arrival of spring or summer.
Researchers have formulated a model to show that the viral loads in infected people and the rate of viral spread in the population have a correlation and these viral loads can be used to measure the spread rates.
During severe COVID-19 infection, the human immune system instigates an excessive inflammatory response.
IIT Kharagpur study has led to the formulation of a set of environmental recommendations for solid waste management under the pandemic situation.
Scientists are searching for a number that can represent the level of severity in COVID-19 infected patients.
The researchers observed that more than 10% of the severely infected people with COVID-19 had autoantibodies that targeted the type-1 interferon activity.
Scientists studied the response of 40 people aged 56 and above to the vaccine developed by the Cambridge based biotechnology firm Moderna.
Shekhar C. Mande, Director-General, CSIR Secretary, DSIR
Cover Story (12)
S&T News (117)
Book Review (6)
Science Fiction (6)
Nature's Marvel (9)
Innovative Minds (8)
CSIR Tech Showcase (5)
Test Your Knowledge (14)
Your comment is under moderation. It will display after admin approval.